Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a way to study human body clocks using hair tissue, which works similarly in both healthy and dementia patients.

Changes in the HR gene have influenced hair growth and may lead to hair loss conditions in humans.

The RORα gene is active in different parts of cashmere goat hair follicles and may be influenced by melatonin, especially in December when hair growth changes.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The hairless gene is crucial for hair health, and its mutations cause hair loss.

YAP1 helps fat cell formation by influencing the Hippo pathway.

Higher CRBP1 levels are linked to more severe alopecia areata.

GPCRs are vital for wound healing by affecting cell growth and immune response.

Researchers found key regions in the mouse hairless gene that control its activity in skin and brain cells, affecting hair follicle function.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

A gene mutation causes curly hair and hair loss in rats.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

Higher RBP4 levels found in people with two types of hair loss.

Retinoic acid causes gland formation instead of hair in mouse skin by altering epidermal and dermal interactions.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.